Pluristem Therapeutics, Inc. News Headlines

PSTI 
$2.93
*  
0.04
1.35%
Get PSTI Alerts
*Delayed - data as of Oct. 22, 2014  -  Find a broker to begin trading PSTI now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Setback for Pluristem Therapeutics - Analyst Blog
6/5/2013 5:27:36 PM - Zacks.com


A Focus On Stem-Cell Therapy And Regenerative Medicine For 2013
5/20/2013 11:38:00 AM - Seeking Alpha


Position Yourself For Big Returns In The Stem Cell Space: Jason Kolbert
5/13/2013 7:08:00 AM - Seeking Alpha


United Therapeutics' Second PAH Stumble Emphasizes The Need For Pluristem's Therapy
4/30/2013 4:19:00 AM - Seeking Alpha


An Industry Outlook With Analyst Vernon Bernardino
4/22/2013 5:30:00 AM - Seeking Alpha


PSTI Plans to Start Phase I Study - Analyst Blog
4/19/2013 4:11:14 PM - Zacks.com


Investing In The Stem Cell Sector: An Overview
4/17/2013 8:36:00 AM - Seeking Alpha


UTHR to Move PAH Drug into Phase I - Analyst Blog
4/15/2013 12:11:40 PM - Zacks.com


The Vatican / NeoStem Partnership Looks To Create Interest And Advance Cell Therapy
4/10/2013 4:00:00 AM - Seeking Alpha


Brainstorm's Breakthrough ALS Clinical Data Shows The Promise In Stem Cell Therapy
3/28/2013 9:14:00 AM - Seeking Alpha


Pipeline Progress at Pluristem - Analyst Blog
3/25/2013 6:31:03 PM - Zacks.com


The Future Of Medicine: A Look At 5 Stem Cell Companies
3/22/2013 11:58:00 AM - Seeking Alpha


Phase II Trials Will Be Pivotal For These Stem Cell Companies
3/20/2013 3:26:00 AM - Seeking Alpha


The Stem Cell Revolution Can Jump Start Your Portfolio: Jason Kolbert
3/15/2013 11:20:00 AM - Seeking Alpha


Pluristem & UTHR Progress with PLX-PAD - Analyst Blog
3/4/2013 6:25:01 PM - Zacks.com


2012 Stem Cell Standouts And The Outlook For 2013
2/28/2013 2:15:00 PM - Seeking Alpha


New Orphan Drug Designation For Pluristem Could Gain Access To FDA 'Progressive Approval'
2/27/2013 5:25:00 AM - Seeking Alpha


3 Regenerative Medicine Companies That Could Deliver In 2013
1/22/2013 9:33:00 AM - Seeking Alpha


Pluristem Progresses with New Facility - Analyst Blog
1/4/2013 7:27:01 PM - Zacks.com


Stem Cells, Dr. Oz And A Potentially Lucrative Investment Opportunity
1/2/2013 4:37:00 PM - Seeking Alpha


Formation Of A New Expert Group Moves Pluristem Into The Expansive Hematology Field
12/5/2012 6:59:00 PM - Seeking Alpha


Maxim Group Highlights 3 Stem Cells Stocks To Consider And 1 To Avoid
12/4/2012 10:03:00 AM - Seeking Alpha


Orphan Status Update from Pluristem - Analyst Blog
11/27/2012 7:00:01 PM - Zacks.com


4 Undervalued And Technically Oversold Healthcare Penny Stocks Poised To Bounce
11/20/2012 9:58:00 AM - Seeking Alpha


An Exciting Week In Cell Therapy
11/12/2012 3:57:00 AM - Seeking Alpha